ScanSource (SCSC) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Feb, 2026Executive summary
Q2 FY26 net sales rose 2.5% year-over-year to $766.5 million, with both segments showing growth and strong free cash flow generation, but profitability declined due to higher period expenses and a slowdown in large deals.
Gross profit increased 1.2% year-over-year to $102.9 million, while gross margin declined by 18 basis points to 13.4%.
GAAP net income was $16.5 million, with diluted EPS of $0.75; six-month net income was $36.4 million, with diluted EPS of $1.63.
Adjusted EBITDA fell 11.6% year-over-year to $31.2 million, with a margin of 4.07%.
The company completed the acquisition of DataXoom in October 2025, expanding its Specialty Technology Solutions segment.
Financial highlights
Operating income for Q2 FY26 was $17.9 million, a 3.1% decrease year-over-year.
Gross profit for the six months ended December 31, 2025, was $210.4 million, up 3.5% year-over-year.
Free cash flow for the first six months of FY26 was $49.7 million.
Cash and cash equivalents at quarter-end were $83.5 million, with total debt of $102.7 million.
Share repurchases totaled $38.7 million in the first half of FY26, with $179 million remaining authorized.
Outlook and guidance
FY26 net sales guidance revised to $3.0–$3.1 billion, down from $3.1–$3.3 billion; Adjusted EBITDA guidance lowered to $140–$150 million.
Free cash flow guidance remains at least $80 million.
Guidance reduction attributed to timing and slowdown of large deals, not product shortages.
Effective tax rate for fiscal 2026, excluding discrete items, expected to be 27.2% to 28.2%.
Management expects capital expenditures for fiscal 2026 to range from $8.0 million to $12.0 million.
Latest events from ScanSource
- Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference5 Mar 2026 - Sales fell but margins, cash flow, and acquisitions support growth amid market uncertainty.SCSC
Q4 202423 Jan 2026 - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 202515 Jan 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference11 Jan 2026 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 20259 Jan 2026 - Recurring revenue now exceeds 30% of gross profit, fueling margin expansion and strategic growth.SCSC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202514 Dec 2025 - Transformation to a converged hardware and recurring revenue model drives growth and margin expansion.SCSC
Raymond James TMT and Consumer Conference10 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid strong cash flow.SCSC
Proxy Filing1 Dec 2025 - Strong cash flow, margin growth, and governance focus highlight FY2025, with key votes ahead.SCSC
Proxy Filing1 Dec 2025